Does LEDIPASVIR Cause Hepatocellular carcinoma? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Hepatocellular carcinoma have been filed in association with LEDIPASVIR (Harvoni). This represents 7.8% of all adverse event reports for LEDIPASVIR.
40
Reports of Hepatocellular carcinoma with LEDIPASVIR
7.8%
of all LEDIPASVIR reports
13
Deaths
5
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From LEDIPASVIR?
Of the 40 reports, 13 (32.5%) resulted in death, 5 (12.5%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR Cause?
Pruritus (230)
Insomnia (225)
Diarrhoea (220)
Haemorrhagic stroke (218)
Tachycardia (218)
Fatigue (217)
Dizziness (216)
Headache (216)
Arthralgia (212)
Sepsis (212)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which LEDIPASVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
LEDIPASVIR vs LEDIPASVIR\SOFOSBUVIR
LEDIPASVIR vs LEFLUNOMIDE
LEDIPASVIR vs LEMBOREXANT
LEDIPASVIR vs LENACAPAVIR
LEDIPASVIR vs LENALIDOMIDE